USNA - USANA Health Sciences, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
1,124,796
1,189,248
1,047,265
1,006,083
918,499
Cost of Revenue
193,739
200,710
179,404
180,190
159,682
Gross Profit
931,057
988,538
867,861
825,893
758,817
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
273,799
275,059
265,094
234,194
208,995
Total Operating Expenses
770,814
800,185
735,357
687,271
617,155
Operating Income or Loss
160,243
188,353
132,504
138,622
141,662
Interest Expense
39
36
46
444
15
Total Other Income/Expenses Net
-750
3,157
2,136
-70
927
Income Before Tax
164,795
191,510
134,640
138,552
142,589
Income Tax Expense
55,874
65,286
72,105
38,511
47,917
Income from Continuing Operations
108,921
126,224
62,535
100,041
94,672
Net Income
108,921
126,224
62,535
100,041
94,672
Net Income available to common shareholders
108,921
126,224
62,535
100,041
94,672
Reported EPS
Basic
-
5.36
2.60
4.09
3.71
Diluted
-
5.12
2.53
3.99
3.59
Weighted average shares outstanding
Basic
-
23,567
24,024
24,485
24,976
Diluted
-
24,642
24,708
25,047
26,354
EBITDA
-
188,353
132,504
138,622
141,662